Investor insights
Sectors invested in
Conjugation Chemistry1
Biopharma1
Biotechnology1
Chemistry1
Clinical1
Antibody Drug Conjugate1
Toxins1
Organic Synthesis1
Antibody-Drug Conjugates1
Antibodies1
Cancer Treatment1
ADC Stability1
Licencing1
Therapeutics1
Cancer research1
Preclinical1
Drug Discovery1
ADCs1
PermaLink™1
Drug Development1
Funding rounds participated in
$47M sweet spot round size
Most of their 1 investments are in rounds between $47M and $47M
Basic info
Industry
biotechnology research
Sectors
manufacture of both biosimilars and new biopharmaceutical products
Biotechnology
development
Health Care
To research
Manufacturing
with a commitment of contributing to the promotion of human health and social welfare.
Date founded
2002
Investments made
I
Iksuda Therapeutics raised $47M on June 7, 2021
Investors: Premier Partners and Celltrion Inc.
Funding rounds raised
C
Celltrion Inc. raised undisclosed on January 1, 2006
Investors: IMM Private Equity